Chapter 1. Introduction
1.1. Research Objective
1.2. Scope of the Study
1.3. Definition
Chapter 2. Research Methodology
2.1. Research Approach
2.2. Data Sources
2.3. Assumptions & Limitations
Chapter 3. Executive Summary
3.1. Market Snapshot
Chapter 4. Market Variables and Scope
4.1. Introduction
4.2. Market Classification and Scope
4.3. Industry Value Chain Analysis
4.3.1. Raw Material Procurement Analysis
4.3.2. Sales and Distribution Channel Analysis
4.3.3. Downstream Buyer Analysis
Chapter 5. Market Dynamics Analysis and Trends
5.1. Market Dynamics
5.1.1. Market Drivers
5.1.2. Market Restraints
5.1.3. Market Opportunities
5.2. Porter’s Five Forces Analysis
5.2.1. Bargaining power of suppliers
5.2.2. Bargaining power of buyers
5.2.3. Threat of substitute
5.2.4. Threat of new entrants
5.2.5. Degree of competition
Chapter 6. Competitive Landscape
6.1.1. Company Market Share/Positioning Analysis
6.1.2. Key Strategies Adopted by Players
6.1.3. Vendor Landscape
6.1.3.1. List of Suppliers
6.1.3.2. List of Buyers
Chapter 7. Global Point Of Care Diagnostics & Testing Market, By Product
7.1. Point Of Care Diagnostics & Testing Market, by Product Type, 2020-2030
7.1.1. Glucose Testing
7.1.1.1. Market Revenue and Forecast (2016-2030)
7.1.2. Hb1Ac Testing
7.1.2.1. Market Revenue and Forecast (2016-2030)
7.1.3. Coagulation
7.1.3.1. Market Revenue and Forecast (2016-2030)
7.1.4. Fertility
7.1.4.1. Market Revenue and Forecast (2016-2030)
7.1.5. Infectious Diseases
7.1.5.1. Market Revenue and Forecast (2016-2030)
7.1.6. Cardiac Markers
7.1.6.1. Market Revenue and Forecast (2016-2030)
7.1.7. Thyroid Stimulating Hormone
7.1.7.1. Market Revenue and Forecast (2016-2030)
7.1.8. Hematology
7.1.8.1. Market Revenue and Forecast (2016-2030)
7.1.9. Primary Care Systems
7.1.9.1. Market Revenue and Forecast (2016-2030)
7.1.10. Decentralized Clinical Chemistry
7.1.10.1. Market Revenue and Forecast (2016-2030)
7.1.11. Feces
7.1.11.1. Market Revenue and Forecast (2016-2030)
7.1.12. Lipid Testing
7.1.12.1. Market Revenue and Forecast (2016-2030)
7.1.13. Cancer Marker
7.1.13.1. Market Revenue and Forecast (2016-2030)
7.1.14. Blood Gas/Electrolytes
7.1.14.1. Market Revenue and Forecast (2016-2030)
7.1.15. Ambulatory Chemistry
7.1.15.1. Market Revenue and Forecast (2016-2030)
7.1.16. Drug Abuse Testing
7.1.16.1. Market Revenue and Forecast (2016-2030)
7.1.17. Urinalysis
7.1.17.1. Market Revenue and Forecast (2016-2030)
Chapter 8. Global Point Of Care Diagnostics & Testing Market, By End-use
8.1. Point Of Care Diagnostics & Testing Market, By End-use, 2020-2030
8.1.1. Clinics
8.1.1.1. Market Revenue and Forecast (2016-2030)
8.1.2. Hospitals
8.1.2.1. Market Revenue and Forecast (2016-2030)
8.1.3. Home
8.1.3.1. Market Revenue and Forecast (2016-2030)
8.1.4. Assisted Living Healthcare Facilities
8.1.4.1. Market Revenue and Forecast (2016-2030)
8.1.5. Laboratory
8.1.5.1. Market Revenue and Forecast (2016-2030)
Chapter 9. Global Point Of Care Diagnostics & Testing Market, Regional Estimates and Trend Forecast
9.1. North America
9.1.1. Market Revenue and Forecast, by Product (2016-2030)
9.1.2. Market Revenue and Forecast, By End-use (2016-2030)
9.1.3. U.S.
9.1.3.1. Market Revenue and Forecast, by Product (2016-2030)
9.1.3.2. Market Revenue and Forecast, By End-use (2016-2030)
9.1.4. Rest of North America
9.1.4.1. Market Revenue and Forecast, by Product (2016-2030)
9.1.4.2. Market Revenue and Forecast, By End-use (2016-2030)
9.2. Europe
9.2.1. Market Revenue and Forecast, by Product (2016-2030)
9.2.2. Market Revenue and Forecast, By End-use (2016-2030)
9.2.3. UK
9.2.3.1. Market Revenue and Forecast, by Product (2016-2030)
9.2.3.2. Market Revenue and Forecast, By End-use (2016-2030)
9.2.4. Germany
9.2.4.1. Market Revenue and Forecast, by Product (2016-2030)
9.2.4.2. Market Revenue and Forecast, By End-use (2016-2030)
9.2.5. France
9.2.5.1. Market Revenue and Forecast, by Product (2016-2030)
9.2.5.2. Market Revenue and Forecast, By End-use (2016-2030)
9.2.6. Rest of Europe
9.2.6.1. Market Revenue and Forecast, by Product (2016-2030)
9.2.6.2. Market Revenue and Forecast, By End-use (2016-2030)
9.3. APAC
9.3.1. Market Revenue and Forecast, by Product (2016-2030)
9.3.2. Market Revenue and Forecast, By End-use (2016-2030)
9.3.3. India
9.3.3.1. Market Revenue and Forecast, by Product (2016-2030)
9.3.3.2. Market Revenue and Forecast, By End-use (2016-2030)
9.3.4. China
9.3.4.1. Market Revenue and Forecast, by Product (2016-2030)
9.3.4.2. Market Revenue and Forecast, By End-use (2016-2030)
9.3.5. Japan
9.3.5.1. Market Revenue and Forecast, by Product (2016-2030)
9.3.5.2. Market Revenue and Forecast, By End-use (2016-2030)
9.3.6. Rest of APAC
9.3.6.1. Market Revenue and Forecast, by Product (2016-2030)
9.3.6.2. Market Revenue and Forecast, By End-use (2016-2030)
9.4. MEA
9.4.1. Market Revenue and Forecast, by Product (2016-2030)
9.4.2. Market Revenue and Forecast, By End-use (2016-2030)
9.4.3. GCC
9.4.3.1. Market Revenue and Forecast, by Product (2016-2030)
9.4.3.2. Market Revenue and Forecast, By End-use (2016-2030)
9.4.4. North Africa
9.4.4.1. Market Revenue and Forecast, by Product (2016-2030)
9.4.4.2. Market Revenue and Forecast, By End-use (2016-2030)
9.4.5. South Africa
9.4.5.1. Market Revenue and Forecast, by Product (2016-2030)
9.4.5.2. Market Revenue and Forecast, By End-use (2016-2030)
9.4.6. Rest of MEA
9.4.6.1. Market Revenue and Forecast, by Product (2016-2030)
9.4.6.2. Market Revenue and Forecast, By End-use (2016-2030)
9.5. Latin America
9.5.1. Market Revenue and Forecast, by Product (2016-2030)
9.5.2. Market Revenue and Forecast, By End-use (2016-2030)
9.5.3. Brazil
9.5.3.1. Market Revenue and Forecast, by Product (2016-2030)
9.5.3.2. Market Revenue and Forecast, By End-use (2016-2030)
9.5.4. Rest of LATAM
9.5.4.1. Market Revenue and Forecast, by Product (2016-2030)
9.5.4.2. Market Revenue and Forecast, By End-use (2016-2030)
Chapter 10. Company Profiles
10.1. F. Hoffmann-La Roche Ltd.
10.1.1. Company Overview
10.1.2. Product Offerings
10.1.3. Financial Performance
10.1.4. Recent Initiatives
10.2. Qiagen
10.2.1. Company Overview
10.2.2. Product Offerings
10.2.3. Financial Performance
10.2.4. Recent Initiatives
10.3. Danaher Corp.
10.3.1. Company Overview
10.3.2. Product Offerings
10.3.3. Financial Performance
10.3.4. Recent Initiatives
10.4. Becton Dickinson (BD)
10.4.1. Company Overview
10.4.2. Product Offerings
10.4.3. Financial Performance
10.4.4. Recent Initiatives
10.5. Biomerieux SA
10.5.1. Company Overview
10.5.2. Product Offerings
10.5.3. Financial Performance
10.5.4. Recent Initiatives
10.6. Abbott Laboratories
10.6.1. Company Overview
10.6.2. Product Offerings
10.6.3. Financial Performance
10.6.4. Recent Initiatives
10.7. Siemens Healthcare AG
10.7.1. Company Overview
10.7.2. Product Offerings
10.7.3. Financial Performance
10.7.4. Recent Initiatives
10.8. Zoetis, Inc.
10.8.1. Company Overview
10.8.2. Product Offerings
10.8.3. Financial Performance
10.8.4. Recent Initiatives
10.9. Instrumentation Laboratory
10.9.1. Company Overview
10.9.2. Product Offerings
10.9.3. Financial Performance
10.9.4. Recent Initiatives
10.10. Nova Biomedical
10.10.1. Company Overview
10.10.2. Product Offerings
10.10.3. Financial Performance
10.10.4. Recent Initiatives
10.11. Trividia Health, Inc.
10.11.1. Company Overview
10.11.2. Product Offerings
10.11.3. Financial Performance
10.11.4. Recent Initiatives
10.12. Quidel Corp.
10.12.1. Company Overview
10.12.2. Product Offerings
10.12.3. Financial Performance
10.12.4. Recent Initiatives
10.13. Trinity Biotech
10.13.1. Company Overview
10.13.2. Product Offerings
10.13.3. Financial Performance
10.13.4. Recent Initiatives
10.14. Sekisui Diagnostics
10.14.1. Company Overview
10.14.2. Product Offerings
10.14.3. Financial Performance
10.14.4. Recent Initiatives
10.15. Orasure Technologies, Inc.
10.15.1. Company Overview
10.15.2. Product Offerings
10.15.3. Financial Performance
10.15.4. Recent Initiatives
10.16. Nipro Corp.
10.16.1. Company Overview
10.16.2. Product Offerings
10.16.3. Financial Performance
10.16.4. Recent Initiatives
10.17. Spectral Medical, Inc
10.17.1. Company Overview
10.17.2. Product Offerings
10.17.3. Financial Performance
10.17.4. Recent Initiatives
Chapter 11. Research Methodology
11.1. Primary Research
11.2. Secondary Research
11.3. Assumptions
Chapter 12. Appendix
12.1. About Us
Glossary of Terms